Fintech PR
Blackmoon Forges Multiple Strategic Partnership to Build New Investable ETx’s
Reading Time: 3 minutes
Blackmoon Financial Group, a blockchain Financial Service and Fintech firm announces multiple partnerships with reputable firms which include of Daneel.io, Plato Technologies Inc., Dr. Werner & Partner, Jarvis International Ltd., Rivver and FintechSauce. The strategic partnerships serve to assist in the creation of branded Exchange Traded Indexes (ETx).
The new partnerships between Blackmoon and these firms will enable them to work very closely together to create a showcase of investable ETx’s that track the performance of a multitude of products, services and sentiment indexes that these firms offer.
Firms partnering with Blackmoon have an advantage over their competitors as they are able to further monetize their offering by making it an investable product.
For example, the partnership with Daneel allows the firm to turn their already successful sentiment API into a feed for an investible ETx, therefore, allowing investors to invest in the hype (or lack thereof) of a particular set of cryptocurrencies.
“As soon as we met in Malta Blockchain Summit, we were directly aligned with market expectations and the collaboration was the logical next step, we are eager to see how investors will react to this new kind of indices made possible by the AI,” said Harold Kinet, Head of Communication at Daneel.
Fintechsauce will roll out a few ETx’s with Blackmoon whose goal will be to create investable ETx’s that track FintechSauce’s investable products.
“In order to succeed in almost any project, you need reliable partners. FintechSauce has been working closely with our clients to be the best financial advisors for them. And now, we are excited about finding the right partner for our business, Blackmoon. With their help, we are creating investment products that will bring financial success to people that believe in us,” said Anastasia Nizhegorodtceva, Associate Director of FintechSauce
On the other hand, the ETx developed with Rivver will track their issued digital assets in real time.
“We are very excited to be collaborating with Blackmoon. Blackmoon’s innovative ETx approach is unique and necessary for the digitized securities ecosystem and we are very happy to be able to offer this added value to our clients,” said David Benizri, CEO of Rivver
Jarvis Exchange’s ETx tracks the performance of a variety coin sets such as “most-traded” and “most-volatile” on the Jarvis Exchange.
“We are very excited to partner with Blackmoon. It is always nice to find companies that share our belief in the collaborative genius. The ETx represent unique investment opportunities. We are happy to bring more value to our users as ETx enhance our offering, and to reveal Blackmoon value proposition to thousands of investors and traders,“ said Pascal Tallarida, Founder & CEO of Jarvis
Furthermore, Plato’s “On-the-fly” ETx’s aim to provide investors with direct access to Plato’s real-time strategies.
“We are really excited about what this partnership means in terms of driving institutional crypto adoption while supporting full compliance across an entire basket of proprietary crypto indexes,” said Bryan Feinberg, CEO of Plato
Dr. Werner & Partner’s ETx, on the other hand, will give investors direct access to Dr Werner & Partner’ client base.
“The partnership with Blackmoon will enable us to extend our (already advanced) crypto advisory services with security token offerings. The amount of interest for that sector is overwhelming and together with Blackmoon we will provide a state-of-the-art-service, that will enable the right client to launch an STO from A-Z,” said Philipp Sauerborn, a senior employee at Dr Werner & Partner
Blackmoon is still working on more partnerships and will announce them as they happen.
Solving the problem of liquidity
Knowing that one can liquidate his or her investment without an impact on price, is a key risk-metric to any and all investment decisions. An STO that supports a thriving and liquid market, immediately increases its perceived value, even if its product, bottom-line or management is not as high a quality as its competitors. The liquidity of the marketplace defines the risk for an investor and the success of the issuer. Without the ease of execution and liquidity, any STO will have limited success, if any at all.
Introducing Blackmoon’s Exchange Traded Indexes (ETx)
Blockchain technology may be a better alternative to raise capital from investors. However, price discovery and trading liquidity also require the inclusion of speculators. The ETx that Blackmoon issues on behalf of its partners’ brands incentivise traders and speculators to take the risk in the market, by offering them a fungible financial product to arbitrage for profit – further adding bids and offers to an STO that would otherwise not exist – effectively creating a balanced and stable price.
“We have seen a surge of interest from firms around the globe, from a variety of sectors, seeking to partner with us specifically to form an investable ETx for them and we are glad that we can fulfil this need. The relationships are mutually beneficial and this serves as the strongest foundation for a long-lasting relationship,“ said Moshe Joshua, Chief Product Officer at Blackmoon
The strategic partnership with Daneel is one of many that Blackmoon intends to form over the coming months. Their ultimate goal will be to have an entire suite of innovative ETx’s to offer their own clients as well as those of their partners.
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Fintech5 days agoHow to identify authenticity in crypto influencer channels
-
Latest News4 days ago
HSBC-backed fintech Monese is considering splitting its operations as it grapples with increasing losses.
-
Latest News4 days ago
EverBank has announced a groundbreaking partnership with Finzly, poised to revolutionize payment processing.
-
Latest News4 days ago
FinTech leaders express caution regarding the promises made in #Budget2024 concerning open banking, stating that the “devil is in the details.”
-
Latest News4 days ago
Gotion High-tech’s operating profit up 391% in 2023, nearly RMB 2.8 billion invested in R&D for the year
-
Latest News4 days ago
Wells Fargo, a leading financial institution, is set to revolutionize its trade finance operations by incorporating artificial intelligence (AI) technology through its collaboration with TradeSun.
-
Latest News3 days ago
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Latest News4 days ago
Latvian Fintech inGain Raises €650,000 for No-Code SaaS Loan Management System